Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-α promote the NF-κB-dependent maturation of normal and leukemic myeloid cells

Journal of Leukocyte Biology

Volumn 74, Issue 2, 2003, Pages 223-232

  Secchiero, Paola ^a   Milani, Daniela ^a   Gonelli, Arianna ^a   Melloni, Elisabetta ^b   Campioni, Diana ^a   Gibellini, Davide ^c   Capitani, Silvano ^a   Zauli, Giorgio ^b  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Myeloid cells; NF B; TNF ; TRAIL

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CD34 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PARTHENOLIDE; PROTEIN P50; PROTEIN P75; SYNAPTOTAGMIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; APOPTOSIS REGULATORY PROTEIN; CASPASE; ENZYME INHIBITOR; I KAPPA B; LIPOCORTIN 5; MEMBRANE PROTEIN; RECOMBINANT PROTEIN; TNFRSF10B PROTEIN, HUMAN; TNFRSF10C PROTEIN, HUMAN; TNFSF10 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR DECOY RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BONE MARROW CELL; CELL MATURATION; CELL STRAIN HL 60; CELL SURFACE; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; ACUTE DISEASE; APOPTOSIS; DRUG ANTAGONISM; GENETIC TRANSFECTION; METABOLISM; MONOCYTE; MYELOID LEUKEMIA; PATHOLOGY; UPREGULATION;

ACUTE DISEASE; ANNEXIN A5; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASPASES; ENZYME INHIBITORS; HL-60 CELLS; HUMANS; I-KAPPA B PROTEINS; LEUKEMIA, MYELOID; MEMBRANE GLYCOPROTEINS; MONOCYTES; NF-KAPPA B; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT PROTEINS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSFECTION; TUMOR NECROSIS FACTOR DECOY RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0042852123     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0103004     Document Type: Article

References (40)

1. Wallach, D., Boldin, M., Varfolomeev, E., Beyaert, R., Vandenabeele, P., Fiers, W. (1997) Cell death induction by receptors of the TNF family: towards a molecular understanding. FEBS Lett. 410, 96-106.
2. Wiley, S. R., Schooley, K., Smolak, P. J., Din, W. S., Huang, C. P., Nicholl, J. K., Sutherland, G. R., Smith, T. D., Rauch, C., Smith, C. A. (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3, 673-682.
3. Pitti, R. M., Marsters, S. A., Ruppert, S., Donahue, C. J., Moore, A., Ashkenazi, A. (1996) Induction of apoptosis by Apn-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 271, 12687-12690.
4. Ashkenazi, A., Dixit, V. M. (1999) Apoptosis control by death and decoy receptors. Curr. Opin. Cell Biol. 11, 255-260.
5. Snell, V., Clodi, K., Zhao, S., Goodwin, R., Thomas, E. K., Morris, S. W., Kadin, M. E., Cabanillas, F., Andreeff, M., Younes, A. (1997) Activity of TNF-related apoptosis-inducing ligand (TRAIL) in haematological malignancies. Br. J. Haematol. 99, 618-624.
6. Clodi, K., Wimmer, D., Li, Y., Goodwin, R., Jaeger, U., Mann, G., Gadner, H., Younes, A. (2000) Expression of tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptors and sensitivity to TRAIL-induced apoptosis in primary B-cell acute lymphoblastic leukaemia cells. Br. J. Haematol. 111, 580-586.
7. Wuchter, C., Krappman, D., Cai, Z., Ruppert, V., Scheidereit, C., Dorken, B., Ludwig, W. D., Karawajew, L. (2001) In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cells in the context of TRAIL receptor gene expression and constitutive NF-kappa B activity. Leukemia 15, 921-928.
8. Mitsiades, C. S., Treon, S. P., Mitsiades, N., Shima, Y., Richardson, P., Schlossman, R., Hideshima, T., Anderson, K. C. (2001) TRAIL/Apo2L selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications. Blood 98, 795-804.
9. Zhang, D. Y., Goodwin, R. G., Loken, M. R., Bryant, E., Deeg, J. (2001) Expression of tumor necrosis factor-related apoptosis-inducing ligand, Apo2L, and its receptors in myelodysplastic syndrome: effects on in vitro hemopoiesis. Blood 98, 3058-3065.
10. Plasilova, M., Zivny, J., Jelinek, J., Neuwirtova, R., Cermak, J., Necas, E., Andera, L., Stopka, T. (2002) TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors. Leukemia 16, 67-73.
11. Silvestris, F., Cafforio, P., Tacci, M., Dammacco, F. (2002) Negative regulation of erythroblast maturation by Fas-L(+)/TRAIL(+) highly malignant plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma. Blood 99, 1305-1313.
12. Uno, K., Inukai, T., Kayagaki, N., Goi, K., Sato, H., Nemoto, A., Takahashi, K., Kagami, K., Yamaguchi, N., Yagita, H., Okumura, K., Koyama-Okazaki, T., Suzuki, T., Sugita, K., Nakazawa, S. (2002) TNF-related apoptosis-inducing ligand (TRAIL) frequently induces apoptosis in Philadelphia chromosome-positive leakemia cells. Blood 101, 3658-3667.
13. De Maria, R., Zeuner, A., Eramo, A., Domenichelli, C., Bonci, D., Grignani, F., Srinivasula, S. M., Alnemri, E. S., Testa, U., Peschle, C. (1999) Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1. Nature 401, 489-493.
14. Zamai, L., Secchiero, P., Pierpaoli, S., Bassini, A., Papa, S., Alnemri, E. S., Guidotti, L., Vitale, M., Zauli, G. (2000) TNF-related apoptosis-inducing ligand (TRAIL) as a negative regulator of normal human erythropoiesis. Blood 95, 3716-3724.
15. Secchiero, P., Gonelli, A., Mirandola, P., Melloni, E., Zamai, L., Celeghini, C., Milani, D., Zauli, G. (2002) TNF-related apoptosis-inducing ligand (TRAIL) induces monocytic maturation of both leukemic and normal myeloid precursors via a caspase-dependent pathway. Blood 100, 2421-2429.
16. Secchiero, P., Gonelli, A., Ciabattoni, G., Melloni, E., Grill, V., Rocca, B., Delbello, G., Zauli, G. (2002) TNF-related apoptosis-inducing ligand (TRAIL) up-regulates cyclooxygenase (COX)-1 activity and PGE(2) production in cells of the myeloid lineage. J. Leukoc. Biol. 72, 986-994.
17. Medupalli, A., Li, Z., Hromchak, R., Bloch, A. (2001) NF-kappaB (p65/RelA) as a regulator of TNF alpha-mediated ML-1 cell differentiation. Leakemia 15, 808-813.
18. Richter, G., Hayden-Ledbetter, M., Irgang, M., Ledbetter, J. A., Westermann, J., Korner, I., Daemen, K., Clark, E. A., Aicher, A., Pezzutto, A. (2001) Tumor necrosis factor-α regulates the expression of inducible costimulator receptor ligand on CD34-progenitor cells during differentiation into antigen presenting cells. J. Biol. Chem. 276, 45686-45693.
19. Sokoloski, J. A., Hodnick, W. F., Mayne, S. T., Ciuquina, C., Kim, C. S., Sartorelli, A. C. (1997) Induction of the differentiation of HL-60 promyelocytic leukemia cells by vitamin E and other antioxidants in combination with low levels of vitamin D3: possible relationship to NF-kappa B. Leukemia 11, 1546-1553.
20. Kang, S. N., Kim, S. H., Chung, S. W., Lee, M. H., Kim, H. J., Kim, T. S. (2002) Enhancement of 1 alpha,25-dihydroxyvitamin D3-induced differentiation of human leukemia HL-60 cells into monocytes by parthenolide via inhibition of NF-kappa B activity. Br. J. Pharmacol. 135, 1235-1244.
21. Karin, M., Lin, A. (2002) NF-κB at the crossroads of life and death. Natl. Immunol. 3, 221-227.
22. Manfredini, R., Trevisan, F., Grande, A., Tagliafico, E., Montanari, M., Lemoli, R., Visani, G., Tura, S., Ferrari, S., Ferrari, S. (1999) Induction of a functional vitamin D receptor in all-trans-retinoic acid-induced monocytic differentiation of M2-type leukemic blast cells. Cancer Res. 59, 3803-3811.
23. Chaudhary, P. M., Ebt, M. T., Jasmin, A., Kumar, A., Liu, L., Hood, L. (2000) Activation of the NF-κB pathway by caspase 8 and its homologs. Oncogenic 19, 4451-4460.
24. Hu, W. H., Johnson, H., Shu, H. B. (1999) Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-κB and JNK activation and apoptosis through distinct pathways. J. Biol. Chem. 274, 30603-30610.
25. Hu, W. H., Johnson, H., Shu, H. B. (2000) Activation of NF-κB by FADD, casper, and caspase 8. J. Biol. Chem. 275, 10838-10844.
26. Harper, N., Farrow, S. N., Kaptein, A., Cohen, G. M., MacFarlane, M. (2001) Modulation of tumor necrosis factor apoptosis-inducing ligand-induced NF-κB activation by inhibition of apical caspases. J. Biol. Chem. 276, 34743-34752.
27. Trauzold, A., Wermann, H., Arlt, A., Schutze, S., Schafer, H., Oestern, S., Roder, C., Ungefroren, H., Lampe, E., Heinrich, M., Walczak, H., Kalthoff, H. (2001) CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-κB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells. Oncogene 20, 4258-4269.
28. Shiiki, K., Yoshikawa, H., Kinoshita, H., Takeda, M., Ueno, A., Nakajima, Y., Tasaka, K. (2000) Potential mechanisms of resistance to TRAIL/ Apo2L-induced apoptosis in human promyelocytic leukemia HL-60 cells during granulocytic differentiation. Cell Death Differ. 7, 939-946.
29. Bernard, D., Quatannens, B., Vandenbunder, B., Abbadie, C. (2001) Rel/NF-κB transcription factors protect against tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by up-regulating the TRAIL decoy receptor DcR1. J. Biol. Chem. 276, 27322-27328.
30. Ravi, R., Bedi, G. C., Engstrom, L. W., Zeng, Q., Mookerjee, B., Gelinas, C., Fuchs, E. J., Bedi, A. (2001) Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-κB. Nat. Cell Biol. 3, 409-416.
31. Chen, X., Kandasamy, K., Srivastava, R. K. (2003) Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappaB in tumor necrosis factor-related apoptosis-inducing ligand signaling. Cancer Res. 63, 1059-1066.
32. Santini, V., Gozzini, A., Scappini, B., Rossi Ferrini, P. (1999) Maturation and apoptosis of primary human acute myeloblastic leukemia cells are determined by TNF-alpha exclusively through CD120A stimulation. Haematologica 84, 291-297.
33. Berry, D. M., Clark, C. S., Meckling-Gill, K. A. (2002) 1alpha,25-Dihydroxyvitamin D3 stimulates phosphorylation of 1kappaBalpha and synergizes with TPA to induce nuclear translocation of NFkappaB during monocytic differentiation of NB4 leukemia cells. Exp. Cell Res. 272, 176-184.
34. Beg, A. A., Sha, W. C., Bronson, R. T., Ghosh, S., Baltimore, D. (1995) Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376, 167-170.
35. Grossmann, M., Metcalf, D., Merryfull, J., Beg, A., Baltimore, D., Gerondakis, S. (1999) The combined absence of the transcription factors Rel and RelA leads to multiple hemopoietic cell defects. Proc. Natl. Acad. Sci. USA 96, 11848-11853.
36. Lin, Y., Cook, A., Keane, M. M., Kelliher, M., Lipkowitz, S., Liu, Z. G. (2000) The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IκB kinase and c-Jun N-terminal kinase. Mol. Cell. Biol. 20, 6638-6645.
37. Wang, J., Lenardo, M. J. (2000) Roles of caspases in apoptosis, development, and cytokine maturation revealed by homozygous gene deficiencies. J. Cell Sci. 113, 753-757.
38. Varfolomeev, E. E., Schuchmann, M., Luria, V., Chiannilkulchai, N., Beckmann, J. S., Mett, I. L., Rebrikov, D., Brodianski, V. M., Kemper, O. C., Kollet, O., Lapidot, T., Soffer, D., Sobe, T., Avraham, K. B., Goncharov, T., Holtmann, H., Lonai, P., Wallach, D. (1998) Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 9, 267-276.
39. Ashkenazi, A., Pai, R. C., Fong, S., Leung, S., Lawrence, D. A., Marsters, S. A., Blackie, C., Chan, L., McMurtrey, A. E., Hebert, A., DeForge, L., Koumenis, I. L., Lewis, D., Harris, L., Bussiere, J., Koeppen, H., Shahrokh, Z., Schwall, R. H. (1999) Safety and antitumor activity of recombinant soluble Apo2 ligand. J. Clin. Invest. 104, 155-162.
40. Walczak, H., Miller, R. E., Ariail, K., Gliniak, B., Griffith, T. S., Kubin, M., Chin, W., Jones, J., Woodward, A., Le, T., Smith, C., Smolak, P., Goodwin, R. G., Rauch, C. T., Schuh, J. C., Lynch, D. H. (1999) Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat. Med. 5, 157-163.